FDA says no evidence yet linking weight loss drugs to suicidal thoughts

The U.S. Food and Drug Administration (FDA) said on Thursday that a preliminary review by the agency did not find evidence that GLP-1 weight loss drugs like Novo Nordisk's (NOVOb.CO) Wegovy are tied to suicidal thoughts.